Richard Sandberg who was Chairman of the Board, becomes Director (news posted on June 25 2019).
Pat Balthrop, who was Director, is promoted to Chairman of the Board (news posted on June 25 2019).
Matthew McLaughlin will join the company as Chief Financial Officer on Apr. 8, 2019 (news posted on March 22 2019).
Create an alert
to follow the executive moves at Oxford Immunotec.
Zambon has acquired Breath Therapeutics (posted on Jul 29, 2019).
Cognizant has announced the acquisition of Zenith Technologies (posted on Jun 18, 2019).
Dassault Systemes has announced the acquisition of Medidata Solutions (posted on Jun 14, 2019).
Oxford Immunotec to Participate in Two Upcoming Investor Conferences | Oxford Immunotec Global PLC
Oxford Immunotec Reports Second Quarter 2019 Financial Results | Oxford Immunotec Global PLC
Press Releases | Oxford Immunotec Global PLC
Oxford Immunotec Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019 | Oxford Immunotec Global PLC
Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman | Oxford Immunotec Global PLC
Oxford Immunotec has 1,288 competitors including Aldeyra Therapeutics (United States (USA)), Janssen Research & Development (United States (USA)) and Charles River Laboratories International (United States (USA)).
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.